Disease associated variation - GWASdb |
Chr | Pos | SNP ID(dbSNP 142) | Ref | Alt | Ori SNP ID | P-value | Drug Name | Drug Anno | GWAS Trait | HPO ID | DO ID | AA | Type | Trait or Drug |
9 | 135062771 | rs870591 | G | A | rs870591 | 0.0008283 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | G | intron | GWASdb_drug |
9 | 135062771 | rs870591 | G | A | rs870591 | 8.28E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | G | intron | GWASdb_drug |
9 | 135064702 | rs11243656 | G | C | rs11243656 | 0.000832 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | G | intron | GWASdb_drug |
9 | 135064702 | rs11243656 | G | C | rs11243656 | 8.32E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | G | intron | GWASdb_drug |
9 | 135064788 | rs11243657 | C | T | rs11243657 | 0.0009056 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | T | intron | GWASdb_drug |
9 | 135064788 | rs11243657 | C | T | rs11243657 | 9.06E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | T | intron | GWASdb_drug |
9 | 135070104 | rs7870760 | A | G | rs7870760 | 0.0008786 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | G | intron | GWASdb_drug |
9 | 135070104 | rs7870760 | A | G | rs7870760 | 8.79E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | G | intron | GWASdb_drug |
9 | 135073967 | rs3739930 | C | T | rs3739930 | 0.000911 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | G | cds-synon | GWASdb_drug |
9 | 135073967 | rs3739930 | C | T | rs3739930 | 9.11E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | G | cds-synon | GWASdb_drug |
9 | 135074063 | rs3739929 | T | C | rs3739929 | 0.0009136 | INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G | TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | A | intron | GWASdb_drug |
9 | 135074063 | rs3739929 | T | C | rs3739929 | 9.14E-04 | LEUCOVORIN|METHOTREXATE | SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | A | intron | GWASdb_drug |
9 | 135042885 | rs883318 | A | G | rs883318 | 6.48E-04 | | | Multiple complex diseases | HPOID:0000118 | NA | G | intron | GWASdb_trait |
9 | 135051942 | rs7851167 | C | A | rs7851167 | 1.28E-05 | | | Creatinine levels | HPOID:0012100|HPOID:0000077 | DOID:784 | A | intron | GWASdb_trait |
9 | 135053756 | rs7039329 | C | T | rs7039329 | 1.53E-05 | | | Creatinine levels | HPOID:0012100|HPOID:0000077 | DOID:784 | T | intron | GWASdb_trait |
9 | 135055814 | rs10116759 | A | C | rs10116759 | 7.71E-05 | | | Creatinine levels | HPOID:0012100|HPOID:0000077 | DOID:784 | A | intron | GWASdb_trait |
9 | 135062771 | rs870591 | G | A | rs870591 | 0.0008283 | | | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | G | intron | GWASdb_trait |
9 | 135062771 | rs870591 | G | A | rs870591 | 8.28E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | G | intron | GWASdb_trait |
9 | 135064702 | rs11243656 | G | C | rs11243656 | 0.000832 | | | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | G | intron | GWASdb_trait |
9 | 135064702 | rs11243656 | G | C | rs11243656 | 8.32E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | G | intron | GWASdb_trait |
9 | 135064788 | rs11243657 | C | T | rs11243657 | 9.06E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | T | intron | GWASdb_trait |
9 | 135070104 | rs7870760 | A | G | rs7870760 | 0.0008786 | | | Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) | HPOID:0001370 | DOID:7148 | G | intron | GWASdb_trait |
9 | 135070104 | rs7870760 | A | G | rs7870760 | 8.79E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | G | intron | GWASdb_trait |
9 | 135073967 | rs3739930 | C | T | rs3739930 | 9.11E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | G | cds-synon | GWASdb_trait |
9 | 135074063 | rs3739929 | T | C | rs3739929 | 9.14E-04 | | | Methotrexate clearance (acute lymphoblastic leukemia) | HPOID:0006721 | DOID:9952|DOID:12603 | A | intron | GWASdb_trait |
9 | 135080098 | rs11243667 | A | G | rs11243667 | 2.02E-04 | | | Multiple complex diseases | HPOID:0000118 | NA | A | intron | GWASdb_trait |
9 | 135096767 | rs11243676 | G | A | rs11243676 | 3.00E-06 | | | Systemic lupus erythematosus | HPOID:0002725 | DOID:9074 | G | intron | GWASdb_trait |
9 | 135099486 | rs6597562 | C | T | rs6597562 | 1.10E-05 | | | Urinary metabolites | HPOID:0000079 | DOID:557 | C | intron | GWASdb_trait |
9 | 135114365 | rs2274853 | G | A | rs2274853 | 6.63E-04 | | | Alcohol dependence | HPOID:0000707 | DOID:0050741 | C | intron | GWASdb_trait |